Overcoming Racial Disparities in Curative Therapies for Hepatocellular Carcinoma

克服肝细胞癌治疗中的种族差异

基本信息

  • 批准号:
    10710051
  • 负责人:
  • 金额:
    $ 15.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-25 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Lauren D. Nephew MD, MA, MSCE's long-term career goal is to become an independent, externally funded researcher and leader in developing multilevel interventions to reduce disparities in access to treatments for liver disease and gastrointestinal malignancies. She has identified improving access to curative therapies for hepatocellular carcinoma (HCC) as a critical issue to address to achieve this goal. This proposal describes a 4-year comprehensive program of training and mentored research for an academic career in health services research with a special focus on advancing health care equity. This is in line with NIDDK's commitment to combating health disparities. While Dr. Nephew has a strong background in epidemiology, this K23 will provide key training in using human centered design research methods for intervention development, randomized controlled behavioral trials, and implementation of interventions within health systems. Black patients with chronic liver disease are approximately 50% less likely than White patients to receive curative therapies for hepatocellular carcinoma (HCC) even when presenting with early stage disease. Reasons for disparities in mortality are in part related to failure to progress through the complex HCC care continuum to access curative therapies as a result of the unequal distribution of social and structural determinants of health (SSDOH). The HCC-EduLink intervention we propose to develop is designed to: a) improve patients' HCC-related knowledge; b) screen patients for social needs and substance use and refer to social work for linkage to local services; and c) use our multidisciplinary HCC tumor board to facilitate linkage to subspecialty HCC cancer care. The objectives of this application are to develop the education program component of the HCC-EduLink intervention and pilot test the full multi-level intervention designed to address patient- and system-level SSDOH variables and facilitate access to HCC curative therapies in a cohort of Black patients HCC. Dr. Nephew's multidisciplinary mentorship team including a world-renowned gastroenterologist, an expert in interventions to reduce cancer disparities, and a behavioral health statistician will provide expert guidance to complement her course work and experiential learning. The environment including the Indiana University Simon Cancer Center, Clinical and Translational Science Institute, the Eskenazi Safety-net Hospital and the Indiana University Academic Health Center, make this an ideal environment for her training and to complete the proposed aims. Upon completion of the proposed research and training, Dr. Nephew will submit a competitive R-level grant to test the pilot intervention in a larger randomized trial and will possess the skills and experience needed to make a sustained and impactful contribution to reduce HCC mortality through evidenced-based interventions in other vulnerable populations.
摘要 劳伦·D侄子MD,MA,MSCE的长期职业目标是成为一名独立的, 资助的研究人员和领导者,制定多层次的干预措施,以减少获得 治疗肝病和胃肠道恶性肿瘤。她已经确定了改善获得治疗性药物的途径, 肝细胞癌(HCC)的治疗是实现这一目标的关键问题。这项建议 描述了一个为期4年的培训和指导研究的学术生涯在 卫生服务研究,特别侧重于促进卫生保健公平。这与NIDDK的 致力于消除健康差距。虽然Dr. Nephew在流行病学方面有很强的背景, K23将提供使用以人为本的设计研究方法进行干预开发的关键培训, 随机对照行为试验,以及在卫生系统内实施干预措施。 患有慢性肝病的黑人患者比白色患者的可能性低约50%, 接受肝细胞癌(HCC)的治愈性治疗,即使在出现早期疾病时。 死亡率差异的原因部分与未能通过复杂的HCC护理取得进展有关 由于社会和结构的不平等分配, 健康决定因素(SSDOH)。我们建议开发的HCC-EduLink干预措施旨在:a) 提高患者HCC相关知识; B)筛查患者的社会需求和物质使用,并参考 社会工作与当地服务联系;以及c)利用我们的多学科HCC肿瘤委员会促进联系 肝癌专科治疗此应用程序的目标是开发教育计划 HCC-EduLink干预措施的组成部分,并对旨在解决以下问题的全面多层次干预措施进行试点测试: 患者和系统水平的SSDOH变量,并促进黑人队列中HCC治愈性治疗的获得 HCC患者。Dr. Nephew的多学科指导团队包括一位世界知名的胃肠病学家, 一位减少癌症差异的干预专家和一位行为健康统计学家将提供专家 指导,以补充她的课程工作和体验式学习。包括印第安纳州 西蒙大学癌症中心、临床和转化科学研究所、埃斯肯纳齐安全网医院 和印第安纳州大学学术健康中心,使这成为一个理想的环境,她的训练, 完成提出的目标。完成拟定研究和培训后,Dr. Nephew将提交 一个有竞争力的R级补助金,以测试试点干预在一个更大的随机试验,并将拥有的技能 需要通过以下方式为降低HCC死亡率做出持续和有影响力的贡献 在其他弱势群体中采取循证干预措施。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hepatic Ischemia/Reperfusion Injury After Liver Transplantation Is Not Associated with Early Impairment of Left Ventricular Ejection Fraction.
  • DOI:
    10.12659/aot.938105
  • 发表时间:
    2022-12-13
  • 期刊:
  • 影响因子:
    1.1
  • 作者:
    Rokop, Zachary P.;Frick, Kyle;Zenisek, Joseph;Kroepfl, Elizabeth;Mihaylov, Plamen;Patidar, Kavish R.;Nephew, Lauren;Mangus, Richard S.;Kubal, Chandrashekhar
  • 通讯作者:
    Kubal, Chandrashekhar
Let's take 2 steps forward.
让我们向前迈出两步。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lauren Nephew其他文献

Lauren Nephew的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lauren Nephew', 18)}}的其他基金

Overcoming Racial Disparities in Curative Therapies for Hepatocellular Carcinoma
克服肝细胞癌治疗中的种族差异
  • 批准号:
    10572610
  • 财政年份:
    2022
  • 资助金额:
    $ 15.25万
  • 项目类别:
Gender disparities in liver transplant: Examining organ acceptance patterns
肝移植中的性别差异:检查器官接受模式
  • 批准号:
    9263688
  • 财政年份:
    2016
  • 资助金额:
    $ 15.25万
  • 项目类别:
Gender disparities in liver transplant: Examining organ acceptance patterns
肝移植中的性别差异:检查器官接受模式
  • 批准号:
    9051217
  • 财政年份:
    2016
  • 资助金额:
    $ 15.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了